Carl Bennet has, through his investment vehicle, executed several insider transactions to increase his holding by 500,000 shares in medical technology group Getinge, where he serves as a board member and principal shareholder.

The total consideration amounts to 96,762,790 kronor, at an average price of 193.53 kronor per share, according to the Swedish Financial Supervisory Authority's insider register.

Prior to these transactions, Bennet controlled 20.38 percent of the capital and 50.30 percent of the voting rights in Getinge, according to ownership data provider Holdings.